Home

Lupin Ltd PE Ratio

Image

Lupin Ltd

NSE: LUPIN

PE

38

Last updated on: Jan 13, 2025

Key Highlights

  • The P/E Ratio of Lupin Ltd is 38 as of 13 Jan 15:12 PM .
  • The P/E Ratio of Lupin Ltd changed from 38.1 on March 2021 to 38.5 on March 2024 . This represents a CAGR of 0.26% over 4 years.
  • The Latest Trading Price of Lupin Ltd is ₹ 2161 as of 13 Jan 15:03 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Lupin Ltd

No data available

Company Fundamentals for Lupin Ltd

Image

Lupin Ltd

NSE: LUPIN

Share Price

₹ 2161.5

-29.00 (-1.32%)

stock direction

Last updated on: Jan 13, 2025

Market Price of Lupin Ltd

1M

1Y

3Y

5Y

Monitoring Lupin Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Jan 20252190.5
09 Jan 20252251.8
08 Jan 20252252.4
07 Jan 20252357.65
06 Jan 20252357.75
03 Jan 20252367.85
02 Jan 20252396.3
01 Jan 20252365
31 Dec 20242350.95
30 Dec 20242309.65

SWOT Analysis Of Lupin Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Lupin Ltd

Asset Value vs Market Value of Lupin Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Lupin Ltd99938
Sun Pharmaceuticals Industries Ltd428533
Divis Laboratories Ltd153076
Cipla Ltd118723
Dr Reddys Laboratories Ltd112998

PE Ratio of Lupin Ltd Explained

``

99938

Market cap

2626

Earnings

38.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lupin Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Lupin Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Lupin Ltd

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.
  • In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd.

Lupin Ltd News Hub

Lupin launches Mirabegron Extended-Release Tablets in US

 Lupin announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, aft

Read more

2024-09-04 00:00:00

Lupin Ltd soars 2.88%

Lupin Ltd is up for a third straight session in a row. The stock is quoting at Rs 2109.95, up 2.88%

Read more

2024-08-09 00:00:00

Broader mkt rallies; metal shares advance

The benchmark indices continued to trade with strong gains in mid-morning trade. The Nifty traded ab

Read more

2024-08-07 00:00:00

Lupin hits 52-week high after Q1 PAT climbs 76% YoY to Rs 801 cr in FY25

Revenue from operations increased 16.28% YoY to Rs 5,514.34 crore during the quarter. Profit before

Read more

2024-08-07 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lupin Ltd

What is the current PE Ratio of Lupin Ltd?

The Current PE Ratio of Lupin Ltd is 38.05 as on 13 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Jan 2025.

What was the PE Ratio of Lupin Ltd last year?

The PE Ratio of Lupin Ltd was 68.56 last year, now the PE ratio is 38.05, showing a year-on-year growth of -44.5%.

What does the PE Ratio of Lupin Ltd indicate about its stock?

The PE Ratio of Lupin Ltd is 38.05. This ratio indicates that investors are willing to pay 38.05 times the earnings per share for each share of Lupin Ltd.

What is the PE Ratio Growth of Lupin Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lupin Ltd grew by -44.5% whereas, the EPS ratio grew by 6.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions